SEC Form 4 · accession 0001185185-17-002634
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director · 10% Owner
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 14, 2017 | S | 25,000 | $0.75 | D | 2,416,994 | D | |
| Common stock | Dec 15, 2017 | S | 25,000 | $0.76 | D | 2,391,994 | D |
Table II — derivative securities
No Table II lines on this filing.